Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

Go back to Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
(NASDAQ: COCH) Delayed: 0.68 +0.01 (1.49%)
Previous Close $0.67    52 Week High
Open $0.64    52 Week Low
Day High $0.73    P/E N/A 
Day Low $0.63    EPS
Volume 319,659